miR-138 might reverse multidrug resistance of leukemia cells

Leukemia Research

Volumn 34, Issue 8, 2010, Pages 1078-1082

  Zhao, Xiaohong ^a   Yang, Li ^a   Hu, Jianguo ^a   Ruan, Jigang ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Leukemia; MiR 138; Multidrug resistance

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; MICRORNA; PROTEIN BCL 2; VINCRISTINE;

APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL STRAIN HL 60; CONTROLLED STUDY; DOWN REGULATION; GENE; GENETIC TRANSCRIPTION; HUMAN; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA; LUCIFERASES; MICRORNAS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; VINCRISTINE;

EID: 77953611097     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.10.002     Document Type: Article

References (19)

1. Au W.Y., Caguioa P.B., Chuah C., et al. Chronic myeloid leukemia in Asia. Int J Hematol 2009, 89:14-23.
2. Wang Q.Z., Xu W., Habib N., Xu R. Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets 2009, 9:572-594.
3. Wang Y., Russell I., Chen C. MicroRNA and stem cell regulation. Curr Opin Mol Ther 2009, 11:292-298.
4. Mishra P.J., Bertino J.R. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 2009, 10:399-416.
5. Liu X., Jiang L., Wang A., Yu J., Shi F., Zhou X. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 2009, (June 18). [Epub ahead of print].
6. Calin G.A., Ferracin M., Cimmino A., et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353:1793-1801.
7. Würdinger T., Tannous B.A., Saydam O., et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008, 14:382-393.
8. Hong L., Wang J., Zhao Y., et al. DARPP-32 mediates multidrug resistance of gastric cancer through regulation of P-gp and ZNRD1. Cancer Invest 2007, 25:699-705.
9. Hong L., Qiao T., Han Y., et al. ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2. Biochem Cell Biol 2006, 84:199-206.
10. Hong L., Wang J., Han Y., et al. Reversal of multidrug resistance of vincristine-resistant gastric adenocarcinoma cells through up-regulation of DARPP-32. Cell Biol Int 2007, 31(9):1010-1015.
11. Guo C., Ding J., Yao L., et al. Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int J Cancer 2005, 116:155-160.
12. Siegel G., Obernosterer G., Fiore R., et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 2009, 11:705-716.
13. Morton S.U., Scherz P.J., Cordes K.R., Ivey K.N., Stainier D.Y., Srivastava D. microRNA-138 modulates cardiac patterning during embryonic development. Proc Natl Acad Sci USA 2008, 105:17830-17835.
14. Hong L., Zhao Y., Wang J., et al. Reversal of multidrug resistance of adriamycin-resistant gastric adenocarcinoma cells through the up-regulation of DARPP-32. Digest Dis Sci 2008, 53:101-107.
15. Artali R., Beretta G., Morazzoni P., Bombardelli E., Meneghetti F. Green tea catechins in chemoprevention of cancer: a molecular docking investigation into their interaction with glutathione S-transferase (GST P1-1). J Enzyme Inhib Med Chem 2009, 24:287-295.
16. Tew K.D. Redox in redux: emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochem Pharmacol 2007, 73:1257-1269.
17. Li K., Lu Y., Liang J., et al. RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax. Biochem Biophys Res Commun 2009, 379:212-216.
18. Obexer P., Hagenbuchner J., Unterkircher T., et al. Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis. Mol Biol Cell 2009, 20:2041-2048.
19. Petronelli A., Saulle E., Pasquini L., et al. High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide. Cancer Lett 2009, 282:214-228.